US Stock MarketDetailed Quotes

BLRX BioLine Rx

Watchlist

0.813
-0.018-2.11%

Close Jul 22 16:00 ET

64.95MMarket Cap-1083P/E (TTM)

BioLine Rx Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-76.01%-14.11M

13.84%-22.61M

187.98%4.99M

-13.91%-9.9M

-53.95%-9.68M

-43.50%-8.02M

-11.31%-26.24M

-3.09%-5.67M

-73.39%-8.69M

7.89%-6.29M

Net income from continuing operations

94.28%-696K

-142.93%-60.61M

-142.26%-13.88M

-134.01%-16.02M

-149.16%-18.55M

-146.69%-12.16M

7.77%-24.95M

-33.16%-5.73M

-19.79%-6.85M

-8.78%-7.44M

Operating gains losses

-248.39%-4.52M

291.38%11.24M

15.66%-3.03M

425.75%3.15M

6,604.84%8.07M

355.54%3.05M

-429.09%-5.87M

-53.33%-3.59M

-26.08%-967K

-178.48%-124K

Depreciation and amortization

246.33%897K

111.62%1.38M

277.54%706K

44.44%221K

40.43%198K

49.71%259K

-6.97%654K

7.47%187K

-8.38%153K

-21.67%141K

Other non cash items

236.09%447K

161.35%1.16M

-200.18%-1.14M

278.62%1.11M

11,900.00%1.06M

304.62%133K

1,041.03%445K

5,533.33%1.14M

-4,684.62%-622K

-150.00%-9K

Change In working capital

-4,045.05%-10.77M

1,127.71%15.2M

1,064.37%14.71M

215.30%1.17M

-216.18%-948K

58.72%273K

329.26%1.24M

111.56%1.26M

-197.03%-1.01M

216.07%816K

-Change in receivables

---2.47M

---358K

----

--0

----

-Change in inventory

---936K

---1.95M

---601K

----

--0

----

-Change in prepaid assets

166.94%81K

-47.54%-959K

-64.44%-393K

41.52%392K

-38.12%-837K

-47.56%-121K

-2,808.33%-650K

-164.25%-239K

-67.94%277K

-156.78%-606K

-Change in payables and accrued expense

-991.12%-3.51M

191.95%5.51M

106.46%3.1M

264.96%2.13M

-107.81%-111K

55.12%394K

434.75%1.89M

567.56%1.5M

-816.67%-1.29M

404.50%1.42M

-Change in other working capital

---3.93M

--12.96M

----

Cash from discontinued investing activities

Operating cash flow

-76.01%-14.11M

13.84%-22.61M

187.82%4.99M

-14.04%-9.9M

-53.95%-9.68M

-43.50%-8.02M

-11.31%-26.24M

-3.27%-5.68M

-73.19%-8.68M

7.89%-6.29M

Investing cash flow

Cash flow from continuing investing activities

151.23%16.69M

-63.95%1.44M

-628.09%-20.4M

127.43%4.1M

10.66%11.1M

31.58%6.64M

110.48%4.01M

-3.40%3.86M

-37,437.50%-14.94M

267.16%10.03M

Net PPE purchase and sale

0.00%-32K

11.45%-116K

71.93%-16K

91.67%-1K

-52.27%-67K

-77.78%-32K

-35.05%-131K

41.24%-57K

-131.58%-12K

-131.58%-44K

Net intangibles purchase and sale

--0

2.16%-181K

98.83%-2K

-85.71%-26K

---56K

---97K

---185K

-588.57%-171K

---14K

--0

Net investment purchase and sale

146.92%16.72M

-59.72%1.74M

-598.22%-20.38M

127.66%4.12M

11.39%11.22M

33.66%6.77M

111.34%4.32M

0.74%4.09M

-40,394.59%-14.91M

268.42%10.08M

Cash from discontinued investing activities

Investing cash flow

151.23%16.69M

-63.95%1.44M

-628.09%-20.4M

127.43%4.1M

10.66%11.1M

31.58%6.64M

110.48%4.01M

-3.40%3.86M

-37,437.50%-14.94M

267.16%10.03M

Financing cash flow

Cash flow from continuing financing activities

-1,724.49%-894K

-26.33%15.06M

1,914.53%11.74M

-84.60%3.5M

80.55%-134K

94.80%-49K

-64.61%20.44M

-471.84%-647K

1,342.35%22.72M

-104.89%-689K

Net issuance payments of debt

-1,724.49%-894K

-132.73%-1.99M

-32.77%-863K

-110.92%-942K

86.00%-134K

94.80%-49K

270.04%6.07M

29.73%-650K

1,083.35%8.62M

-5.51%-957K

Net common stock issuance

----

-1.88%14.09M

--12.19M

-86.55%1.9M

----

-71.51%14.36M

--0

474.76%14.09M

----

Proceeds from stock option exercised by employees

----

59,000.00%2.96M

13,566.67%410K

--2.55M

----

-99.95%5K

--3K

--0

----

Cash from discontinued financing activities

Financing cash flow

-1,724.49%-894K

-26.33%15.06M

1,914.53%11.74M

-84.60%3.5M

80.55%-134K

94.80%-49K

-64.61%20.44M

-471.84%-647K

1,342.35%22.72M

-104.89%-689K

Net cash flow

Beginning cash position

-59.81%4.26M

-18.50%10.59M

-41.04%7.73M

-27.83%10.1M

-20.79%9.07M

-18.50%10.59M

-22.82%12.99M

-6.90%13.11M

-19.93%14M

-28.67%11.45M

Current changes in cash

218.34%1.68M

-240.09%-6.11M

-48.46%-3.66M

-156.11%-2.31M

-57.94%1.28M

3.92%-1.42M

55.63%-1.8M

-85.42%-2.47M

73.51%-900K

141.53%3.05M

Effect of exchange rate changes

152.04%51K

63.10%-224K

484.00%192K

-1,540.00%-72K

50.70%-246K

-55.56%-98K

-393.24%-607K

-120.49%-50K

155.56%5K

-388.44%-499K

End cash Position

-33.93%5.99M

-59.81%4.26M

-41.04%7.73M

-27.83%10.1M

-20.79%9.07M

-18.50%10.59M

-6.90%13.11M

-19.93%14M

Free cash flow

-73.62%-14.14M

13.75%-22.91M

184.13%4.97M

-14.01%-9.93M

-54.82%-9.81M

-45.34%-8.15M

-12.19%-26.56M

-6.22%-5.91M

-73.81%-8.71M

7.51%-6.33M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-76.01%-14.11M	13.84%-22.61M	187.98%4.99M	-13.91%-9.9M	-53.95%-9.68M	-43.50%-8.02M	-11.31%-26.24M	-3.09%-5.67M	-73.39%-8.69M	7.89%-6.29M
Net income from continuing operations	94.28%-696K	-142.93%-60.61M	-142.26%-13.88M	-134.01%-16.02M	-149.16%-18.55M	-146.69%-12.16M	7.77%-24.95M	-33.16%-5.73M	-19.79%-6.85M	-8.78%-7.44M
Operating gains losses	-248.39%-4.52M	291.38%11.24M	15.66%-3.03M	425.75%3.15M	6,604.84%8.07M	355.54%3.05M	-429.09%-5.87M	-53.33%-3.59M	-26.08%-967K	-178.48%-124K
Depreciation and amortization	246.33%897K	111.62%1.38M	277.54%706K	44.44%221K	40.43%198K	49.71%259K	-6.97%654K	7.47%187K	-8.38%153K	-21.67%141K
Other non cash items	236.09%447K	161.35%1.16M	-200.18%-1.14M	278.62%1.11M	11,900.00%1.06M	304.62%133K	1,041.03%445K	5,533.33%1.14M	-4,684.62%-622K	-150.00%-9K
Change In working capital	-4,045.05%-10.77M	1,127.71%15.2M	1,064.37%14.71M	215.30%1.17M	-216.18%-948K	58.72%273K	329.26%1.24M	111.56%1.26M	-197.03%-1.01M	216.07%816K
-Change in receivables	---2.47M	---358K	----	----	----	--0	--0	----	----	----
-Change in inventory	---936K	---1.95M	---601K	----	----	--0	--0	--0	----	----
-Change in prepaid assets	166.94%81K	-47.54%-959K	-64.44%-393K	41.52%392K	-38.12%-837K	-47.56%-121K	-2,808.33%-650K	-164.25%-239K	-67.94%277K	-156.78%-606K
-Change in payables and accrued expense	-991.12%-3.51M	191.95%5.51M	106.46%3.1M	264.96%2.13M	-107.81%-111K	55.12%394K	434.75%1.89M	567.56%1.5M	-816.67%-1.29M	404.50%1.42M
-Change in other working capital	---3.93M	--12.96M	----	----	----	----	----	----	----	----
Cash from discontinued investing activities
Operating cash flow	-76.01%-14.11M	13.84%-22.61M	187.82%4.99M	-14.04%-9.9M	-53.95%-9.68M	-43.50%-8.02M	-11.31%-26.24M	-3.27%-5.68M	-73.19%-8.68M	7.89%-6.29M
Investing cash flow
Cash flow from continuing investing activities	151.23%16.69M	-63.95%1.44M	-628.09%-20.4M	127.43%4.1M	10.66%11.1M	31.58%6.64M	110.48%4.01M	-3.40%3.86M	-37,437.50%-14.94M	267.16%10.03M
Net PPE purchase and sale	0.00%-32K	11.45%-116K	71.93%-16K	91.67%-1K	-52.27%-67K	-77.78%-32K	-35.05%-131K	41.24%-57K	-131.58%-12K	-131.58%-44K
Net intangibles purchase and sale	--0	2.16%-181K	98.83%-2K	-85.71%-26K	---56K	---97K	---185K	-588.57%-171K	---14K	--0
Net investment purchase and sale	146.92%16.72M	-59.72%1.74M	-598.22%-20.38M	127.66%4.12M	11.39%11.22M	33.66%6.77M	111.34%4.32M	0.74%4.09M	-40,394.59%-14.91M	268.42%10.08M
Cash from discontinued investing activities
Investing cash flow	151.23%16.69M	-63.95%1.44M	-628.09%-20.4M	127.43%4.1M	10.66%11.1M	31.58%6.64M	110.48%4.01M	-3.40%3.86M	-37,437.50%-14.94M	267.16%10.03M
Financing cash flow
Cash flow from continuing financing activities	-1,724.49%-894K	-26.33%15.06M	1,914.53%11.74M	-84.60%3.5M	80.55%-134K	94.80%-49K	-64.61%20.44M	-471.84%-647K	1,342.35%22.72M	-104.89%-689K
Net issuance payments of debt	-1,724.49%-894K	-132.73%-1.99M	-32.77%-863K	-110.92%-942K	86.00%-134K	94.80%-49K	270.04%6.07M	29.73%-650K	1,083.35%8.62M	-5.51%-957K
Net common stock issuance	----	-1.88%14.09M	--12.19M	-86.55%1.9M	----	----	-71.51%14.36M	--0	474.76%14.09M	----
Proceeds from stock option exercised by employees	----	59,000.00%2.96M	13,566.67%410K	--2.55M	----	----	-99.95%5K	--3K	--0	----
Cash from discontinued financing activities
Financing cash flow	-1,724.49%-894K	-26.33%15.06M	1,914.53%11.74M	-84.60%3.5M	80.55%-134K	94.80%-49K	-64.61%20.44M	-471.84%-647K	1,342.35%22.72M	-104.89%-689K
Net cash flow
Beginning cash position	-59.81%4.26M	-18.50%10.59M	-41.04%7.73M	-27.83%10.1M	-20.79%9.07M	-18.50%10.59M	-22.82%12.99M	-6.90%13.11M	-19.93%14M	-28.67%11.45M
Current changes in cash	218.34%1.68M	-240.09%-6.11M	-48.46%-3.66M	-156.11%-2.31M	-57.94%1.28M	3.92%-1.42M	55.63%-1.8M	-85.42%-2.47M	73.51%-900K	141.53%3.05M
Effect of exchange rate changes	152.04%51K	63.10%-224K	484.00%192K	-1,540.00%-72K	50.70%-246K	-55.56%-98K	-393.24%-607K	-120.49%-50K	155.56%5K	-388.44%-499K
End cash Position	-33.93%5.99M	-59.81%4.26M	-59.81%4.26M	-41.04%7.73M	-27.83%10.1M	-20.79%9.07M	-18.50%10.59M	-18.50%10.59M	-6.90%13.11M	-19.93%14M
Free cash flow	-73.62%-14.14M	13.75%-22.91M	184.13%4.97M	-14.01%-9.93M	-54.82%-9.81M	-45.34%-8.15M	-12.19%-26.56M	-6.22%-5.91M	-73.81%-8.71M	7.51%-6.33M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall